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COMMENTARY
Undefined cellulase formulations hinder 
scientific reproducibility
Michael E. Himmel1, Charles A. Abbas2, John O. Baker1, Edward A. Bayer3, Yannick J. Bomble1, Roman Brunecky1, 
Xiaowen Chen4, Claus Felby5, Tina Jeoh6, Rajeev Kumar7, Barry V. McCleary8, Brett I. Pletschke9, 
Melvin P. Tucker2, Charles E. Wyman7 and Stephen R. Decker1*
Abstract 
In the shadow of a burgeoning biomass-to-fuels industry, biological conversion of lignocellulose to fermentable 
sugars in a cost-effective manner is key to the success of second-generation and advanced biofuel production. For 
the effective comparison of one cellulase preparation to another, cellulase assays are typically carried out with one or 
more engineered cellulase formulations or natural exoproteomes of known performance serving as positive controls. 
When these formulations have unknown composition, as is the case with several widely used commercial products, it 
becomes impossible to compare or reproduce work done today to work done in the future, where, for example, such 
preparations may not be available. Therefore, being a critical tenet of science publishing, experimental reproducibility 
is endangered by the continued use of these undisclosed products. We propose the introduction of standard proce-
dures and materials to produce specific and reproducible cellulase formulations. These formulations are to serve as 
yardsticks to measure improvements and performance of new cellulase formulations.
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Background
Beginning with the discovery (or reaffirmation reports 
of plant extracts that degrade cellulose were reported 
in the late 1800s [1].) of biological cellulose degradation 
during World War II by the U.S. Army Natick Labs, the 
task of quantifying cellulase action has been challenging 
[2]. Most “cellulase” preparations are complex mixtures 
of several enzyme activities, some active on cellulose, 
some on other biomass components, such as xylan and 
pectin, and, especially in whole broths and commer-
cial preparations, many component proteins are present 
without any apparent biomass-related activity. This com-
plexity also makes it very difficult to obtain an accurate 
protein concentration value, as different components 
react variably to the various protein concentration rea-
gents, and the types and ratios of the protein components 
vary significantly by the source microbe. True cellulases, 
i.e., the endocellulase, exocellulase, and β-d-glucosidase 
enzymes, work synergistically on insoluble substrates, 
so classical Michaelis–Menten enzyme kinetics do not 
apply. The substrate itself, cellulose from plant cell walls, 
displays compositional and structural variability based 
on source and processing methodology. Due to these and 
other complications, measurement of cellulase activity 
has always been challenging, in terms of both standard-
ized assays and reproducibility.
Most early reports of cellulase kinetics relied on the 
simple measurement of soluble sugar released from filter 
paper [3–5]. In 1987, T.K. Ghose reported the develop-
ment of the so-called “filter paper unit (FPU),” measured 
by a dilution series of the cellulase solution, wherein 
the dilution releasing 2.0 mg of equivalent glucose from 
a 50  mg coupon of Whatman No. 1 filter paper in 1  h 
was used to calculate FPU [6]. This measurement was 
established to provide a relatively simple assay to com-
pare cellulases in different research laboratories, but is 
fraught with problems, such as low conversion extent 
(3.6%), complex reagents (i.e., 3,5-dinitrosalicylic acid), 
and operational issues, such as folded versus rolled filter 
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paper and different tube diameters giving different results 
[7]. Notably, detection of FPUs below one FPU was not 
possible. The most problematic issue, however, is that it 
is a volumetric measure of activity typically used to assess 
highly concentrated commercial cellulases, requiring 
large dilutions which lead to large errors and giving little 
or no specific activity information.
For decades, experimental fungal and bacterial cel-
lulases were prepared in the laboratories of the primary 
user. In the early 1990s, standard enzyme preparations 
appeared for sale from several enzyme producers, includ-
ing Biocellulase TRI (Quest Intl.), Celluclast 1.5L (Novo 
Nordisk), Cellulase AP30K (Amano Enzyme), Cellu-
lase TRL (Solvay Enzymes), Econase (Alko-EDC), Mul-
tifect CL, GC and Spezyme #1, #2, #3 (Genencor Intl.), 
and ultra-low microbial (ULM) (Iogen). These early 
commercial enzyme preparations were largely unadul-
terated microbial culture broths, usually filtered, concen-
trated, and stabilized for storage [8]. During this time, 
most reports of new cellulases or application of known 
enzymes to modified substrates included digestion data 
with one or more of these first-generation commercial 
cellulase preparations.
Today, advanced commercial cellulases, often formu-
lated for increased efficacy on biomass, are used as rea-
gents in many lignocellulose conversion experiments, 
including the evaluation of different biomass types for 
improved conversion properties, finding more effec-
tive biomass pretreatment methods, augmenting direct 
microbial conversion of biomass, and as a comparator 
or base formulation for experimentally improved cel-
lulases. Most laboratories measuring cellulase perfor-
mance generate hydrolysis progress curves on different 
substrates, where glucose release (cellobiases are often 
used to convert the cellobiose generated by cellobiohy-
drolases to glucose to simplify the quantitation of sugar 
release) is plotted against time. For industrial purposes, a 
“time-to-target” value is normally calculated. Just as criti-
cally, the enzymes used are more frequently loaded on a 
mass or protein, not FPU, basis. For example, the cellu-
lase loading (in mg protein/g cellulose content) that gives 
a bioethanol process-relevant conversion target of cellu-
losic substrate (often 80%) has been determined for each 
enzyme formulation under study [9]. It should be noted 
that when using mg protein/g loadings, the method used 
to determine protein concentration should be specified, 
as there is variability between assays [10].
Commercial cellulases are often highly concentrated 
and formulated for protein solubility and stability in stor-
age. Both precipitation of protein when diluted and loss 
of activity during long-term storage have been observed 
by our lab and others [11]. While the mechanisms behind 
these phenomena are not clear, these variables also 
impact activity comparisons. Furthermore, due to the 
variability of the biomass itself and the differential effects 
of various pretreatments on digestibility of biomass, 
some attempt should also be made to provide a refer-
ence digestion on an insoluble model substrate, such as 
commercially available microcrystalline cellulose (e.g., 
Avicel) or other appropriate model substrates. However, 
these model substrates have also been observed to have 
some composition and digestibility variations between 
batches. We note that the National Institute of Standards 
and Technology (NIST) has a series of biomass standards 
available and that these materials have shown stability in 
their composition over long-term storage; however, care 
must be taken to account for moisture content and sub-
strate changes due to temperature fluctuations and stor-
age conditions after being received [12].
Observed problem
More recently, a new and disturbing trend has been 
observed in the reporting of cellulase action. To provide 
some context, it is a long-standing tenet in the publica-
tion of scientific data that ALL work described should 
be repeatable [13–15]. In other words, anyone reason-
ably skilled in the art should be able to repeat precisely 
the published results of another laboratory—regard-
less of the time delay. For cellulase research, however, 
the widespread use of newly developed, improved, and 
proprietary cellulase formulations possesses just such 
a publishing dilemma, as these have been developed for 
industrial use, not basic research. Certain commercial 
cellulase preparations, such as Novozymes’  Cellic® series 
 (Cellic® Ctec2 and Ctec3) and  Celluclast® 1.5L, DuPont’s 
 Accellerase® line  (Accellerase® 1000, 1500, Duet, Trio), 
as well as cellulases from DSM, Primalco, Amano, and 
other enzyme suppliers that are used widely today for 
comparison or baselining purposes, have proprietary for-
mulations. A quick PubMed search of the terms “Accel-
lerase”, “Cellic”, and “Celluclast” yielded 45, 52, and 154 
articles, respectively. Users are provided with these for-
mulations only after signing agreements that state that 
they will not endeavor to reverse engineer or otherwise 
determine the enzyme complement constituting the for-
mation. While this is certainly understandable and com-
mon from a commercial product protection point of 
view, it imposes significant limitations on the repeatabil-
ity and understanding of biomass conversion research. 
As these formulations are not readily available to all 
researchers and their production is often discontinued 
in favor of new and improved variations, we propose that 
this practice violates the primary publishing tenet given 
above. This problem is further complicated by the limited 
shelf life of certain products, with activity losses occur-
ring over time, even under proper storage conditions and 
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exacerbated by large differences in measuring protein 
content using different methods and in different labora-
tories. In short, use of commercial cellulases as the only 
experimental means of comparison is nearly impossible 
to reproduce accurately and should be discouraged. But 
what are the alternatives?
Conclusions and solutions
Despite all of its problems, the establishment of the fil-
ter paper assay as the standard cellulase test method was 
a marked improvement in comparability and consist-
ency across cellulase research groups and eventually led 
to a more uniform and precise method based on sugar 
release over time by a known mass of enzymes. Simi-
larly, we need a “standard cellulase assay” using a defined 
and reproducible cellulase formulation and consistent 
substrate, both of which are readily available to anyone 
in the field. Independent testing, characterization, and 
validation of commercial cellulases have always been, 
and will continue to be, critical to development of bio-
mass conversion technology and a robust bioeconomy, 
but the lack of a consistent yardstick by which to meas-
ure improvements and performance of these crucial cata-
lysts continues to confound and restrict advances in this 
field. It is time for a benchmark standard cellulase assay. 
This assay should use well-characterized substrate(s), 
preferably a “cellulose substrate,” to standardize enzyme 
preparations on a “defined” substrate, as well as a “bio-
mass substrate” that could demonstrate performance of 
the enzymes under study on commercially relevant sub-
strates. Avicel is often used as the cellulose substrate and 
could certainly become the cellulose standard material. 
A lignocellulosic biomass standard is more complicated, 
although it is likely that several variants would be needed, 
including a grass (corn stover or wheat straw), a hard-
wood (hybrid poplar), and perhaps a softwood (loblolly 
or southern white pine). Furthermore, the inclusion of 
cellulose-oxidizing LPMO enzymes in cellulase prepara-
tions may complicate a standard cellulase assay. The assay 
should make it possible to regulate the LPMO activity 
by controlling whether or not an electron donor for the 
LPMO is present. A finalized list is beyond the scope of 
this article but these suggestions are as good a place as 
any to start.
We propose that publishers refrain from accepting 
manuscripts wherein such proprietary formulations are 
used as the ONLY means for comparison. We also sug-
gest that experimental solutions should be explored; for 
example, laboratories using cellulases routinely should 
(A) prepare these enzymes locally using designated 
type strains and standardized procedures for growing, 
processing, and quantifying fungal (Trichoderma ree-
sei or others) and bacterial (Clostridium thermocellum 
or others) cellulases reproducibly and/or (B) establish 
an international consortium or single-source supplier 
for archiving, testing, characterizing, and distribut-
ing cellulase preparations of known performance and 
composition along with clearly defined protocols and 
standardized substrate(s). Option A presents its own 
problems of consistency, whereas alternative B would 
require significant administrative and production costs. 
Potential funding for this effort is not apparent, although 
potentially could be made available from a consortium of 
international governmental funding agencies, as part of a 
governmental standardizing agency (i.e., NIST), or from 
a trade association of cellulase producers. Even a single, 
standardized, and consistent commercial cellulase prepa-
ration would be desirable if it was constantly and readily 
available. The inclusion of one of these “standard” cellu-
lase formulations should be a required control or inter-
nal standard when publishing cellulase assay results using 
commercial enzyme formulations. Such a standard will 
provide much more consistent comparisons between 
laboratories and cellulase formulations and expedite dis-
semination and implementation of improved cellulases, 
regardless of the source.
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